Suchbegriffe: BH3-MIMETICS, . Treffer: 4
Moujalled, DM; Brown, FC; Chua, CC; Dengler, MA; Pomilio, G; Anstee, NS; Litalien, V; Thompson, E; Morley, T; MacRaild, S; Tiong, IS; Morris, R; Dun, K; Zordan, A; Shah, J; Banquet, S; Halilovic, E; Morris, E; Herold, MJ; Lessene, G; Adams, JM; Huang, DCS; Roberts, AW; Blombery, P; Wei, AH
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Blood. 2023; 141(6):634-644
Doi: 10.1182/blood.2022016090
Web of Science
PubMed
FullText
FullText_MUG
Odinius, TO; Buschhorn, L; Wagner, C; Hauch, RT; Dill, V; Dechant, M; Buck, MC; Shoumariyeh, K; Moog, P; Schwaab, J; Reiter, A; Brockow, K; Götze, K; Bassermann, F; Höckendorf, U; Branca, C; Jost, PJ; Jilg, S
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
J CANCER RES CLIN. 2021;
Doi: 10.1007/s00432-021-03827-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Thijssen, R; Diepstraten, ST; Moujalled, D; Chew, E; Flensburg, C; Shi, MX; Dengler, MA; Litalien, V; MacRaild, S; Chen, M; Anstee, NS; Reljić, B; Gabriel, SS; Djajawi, TM; Riffkin, CD; Aubrey, BJ; Chang, C; Tai, L; Xu, Z; Morley, T; Pomilio, G; Bruedigam, C; Kallies, A; Stroud, DA; Bajel, A; Kluck, RM; Lane, SW; Schoumacher, M; Banquet, S; Majewski, IJ; Strasser, A; Roberts, AW; Huang, DCS; Brown, FC; Kelly, GL; Wei, AH
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.
Blood. 2021; 137(20): 2721-2735.
Doi: 10.1182/blood.2020010167
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Roca-Portoles, A; Rodriguez-Blanco, G; Sumpton, D; Cloix, C; Mullin, M; Mackay, GM; O'Neill, K; Lemgruber, L; Luo, X; Tait, SWG
Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition.
Cell Death Dis. 2020; 11(8): 616
Doi: 10.1038/s41419-020-02867-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG